These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 2831259)
1. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility. Weishaar RE; Kobylarz-Singer DC; Quade MM; Steffen RP; Kaplan HR J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):513-27. PubMed ID: 2831259 [TBL] [Abstract][Full Text] [Related]
2. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. Weishaar RE; Quade MM; Schenden JA; Evans DB J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170 [TBL] [Abstract][Full Text] [Related]
3. Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Weishaar RE; Kobylarz-Singer DC; Steffen RP; Kaplan HR Circ Res; 1987 Oct; 61(4):539-47. PubMed ID: 2820608 [TBL] [Abstract][Full Text] [Related]
5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
6. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165 [TBL] [Abstract][Full Text] [Related]
7. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor. Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885 [TBL] [Abstract][Full Text] [Related]
8. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea. Ellis JL; Conanan ND J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355 [TBL] [Abstract][Full Text] [Related]
9. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors. Kelly JJ; Barnes PJ; Giembycz MA Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352 [TBL] [Abstract][Full Text] [Related]
10. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue. Price B; Pyne NJ; Houslay MD Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712 [TBL] [Abstract][Full Text] [Related]
11. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle. Barnette MS; Manning CD; Price WJ; Barone FC J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736 [TBL] [Abstract][Full Text] [Related]
12. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Souness JE; Diocee BK; Martin W; Moodie SA Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604 [TBL] [Abstract][Full Text] [Related]
13. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties. Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320 [TBL] [Abstract][Full Text] [Related]
14. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. Muller B; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603 [TBL] [Abstract][Full Text] [Related]
15. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases. Kuo JF; Shoji M; Brackett NL; Helfman DM J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641 [TBL] [Abstract][Full Text] [Related]
16. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine. Miot F; Erneux C; Wells JN; Dumont JE Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949 [TBL] [Abstract][Full Text] [Related]
17. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium. Bode DC; Hamel LT; Wax MB J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791 [TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Rose RJ; Liu H; Palmer D; Maurice DH Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930 [TBL] [Abstract][Full Text] [Related]
19. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments. Weiss RM; Wheeler MA J Pharmacol Exp Ther; 1988 Nov; 247(2):630-4. PubMed ID: 2846825 [TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle. Vargas ML; Hernandez J; Kaumann AJ Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]